We are live on
!
Find out more
GTCM
Gyon Technologies Capital Management Portfolio holdings
AUM
$267M
1-Year Est. Return
11.62%
This Fund
S&P 500
This Quarter
Est. Return
+1.76%
1 Year Est. Return
-11.62%
3 Year Est. Return
+42.22%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$371M
AUM Growth
+$65.9M
(+22%)
Cap. Flow
+$67.5M
Cap. Flow
% of AUM
18.18%
Top 10 Holdings %
Top 10 Hldgs %
12.07%
Holding
522
New
181
Increased
107
Reduced
74
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.22M |
| 2 |
TJX Companies
TJX
|
+$4.48M |
| 3 |
AstraZeneca
AZN
|
+$4.01M |
| 4 |
Canadian National Railway
CNI
|
+$3.93M |
| 5 |
Deere & Co
DE
|
+$3.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$3.51M |
| 2 |
PayPal
PYPL
|
+$3.48M |
| 3 |
Acuity Brands
AYI
|
+$3.39M |
| 4 |
Pfizer
PFE
|
+$3.35M |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.31% |
| 2 | Technology | 18.47% |
| 3 | Healthcare | 15.14% |
| 4 | Industrials | 12.83% |
| 5 | Consumer Discretionary | 12.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Hasbro
HAS
$13B
| $500K | 0.13% |
+5,608
| New | +$545K |
|
202
Outset Medical
OM
$95.1M
| $496K | 0.13% |
+669
| New | +$456K |
|
203
Waters Corp
WAT
$38.7B
| $495K | 0.13% |
1,386
-94
| -6% | -$36.8K |
|
204
Gossamer Bio
GOSS
$87.4M
| $493K | 0.13% |
+39,239
| New | +$361K |
|
205
Loews
L
$23.7B
| $489K | 0.13% |
+9,063
| New | +$492K |
|
206
MACOM Technology Solutions
MTSI
$20.7B
| $479K | 0.13% |
7,379
+1,075
| +17% | +$66K |
|
|
RETA
207
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $478K | 0.13% |
+4,753
| New | +$557K |
|
208
Accenture
ACN
$104B
| $472K | 0.13% |
+1,474
| New | +$479K |
|
209
Everest Group
EG
$14.3B
| $472K | 0.13% |
+1,881
| New | +$482K |
|
|
GTM
210
ZoomInfo Technologies
GTM
$1.07B
| $469K | 0.13% |
+7,668
| New | +$459K |
|
211
Huntsman Corp
HUN
$1.83B
| $468K | 0.13% |
15,806
+5,337
| +51% | +$141K |
|
212
Leggett & Platt
LEG
$1.43B
| $464K | 0.13% |
+10,356
| New | +$499K |
|
213
RH
RH
$3.76B
| $463K | 0.12% |
694
-1,902
| -73% | -$1.31M |
|
214
Nasdaq
NDAQ
$52.9B
| $457K | 0.12% |
+7,101
| New | +$447K |
|
215
First Financial Bankshares
FFIN
$5.07B
| $449K | 0.12% |
+9,762
| New | +$463K |
|
|
NSA
216
DELISTED
National Storage Affiliates Trust
NSA
| $449K | 0.12% |
8,509
-486
| -5% | -$26.8K |
|
217
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$47B
| $447K | 0.12% |
1,321
+253
| +24% | +$88.4K |
|
218
Waste Management
WM
$89.9B
| $445K | 0.12% |
+2,980
| New | +$446K |
|
219
State Street
STT
$51.8B
| $443K | 0.12% |
5,227
-19,304
| -79% | -$1.68M |
|
220
Arcosa
ACA
$7.14B
| $442K | 0.12% |
+8,818
| New | +$457K |
|
221
Mohawk Industries
MHK
$9.24B
| $429K | 0.12% |
2,419
-14,303
| -86% | -$2.77M |
|
222
Choice Hotels
CHH
$5.05B
| $428K | 0.12% |
+3,386
| New | +$405K |
|
223
Vishay Intertechnology
VSH
$5.57B
| $426K | 0.11% |
+21,213
| New | +$459K |
|
224
State Street Materials Select Sector SPDR ETF
XLB
$8.66B
| $426K | 0.11% |
10,766
+1,196
| +12% | +$49.7K |
|
225
Silicon Motion
SIMO
$8.91B
| $425K | 0.11% |
6,158
+1,430
| +30% | +$101K |
|
Similar funds
CDIA
ACMV
SCM
RW
A
CAN
JW
APP
Gyon Technologies Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Gyon Technologies Capital Management held 522 positions worth $371M, up 22% from $305M the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Gyon Technologies Capital Management deployed $67.5M of net new capital in Q3 2021, opening 181 new positions and adding to 107 existing holdings. Its largest new stake was AstraZeneca: 34,466 shares worth $4.14M.
By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $3.35M trimmed.
- Gyon Technologies Capital Management's largest Q3 2021 buy was AstraZeneca: 34,466 shares worth $4.14M.
- Gyon Technologies Capital Management added most to Microsoft in Q3 2021, an estimated $5.22M increase.
- Gyon Technologies Capital Management's biggest Q3 2021 reduction was Pfizer, cutting an estimated $3.35M.
- Gyon Technologies Capital Management fully exited Alphabet (Google) Class A in Q3 2021, selling an estimated $3.51M.
- Gyon Technologies Capital Management's ten largest holdings make up 12% of its $371M portfolio in Q3 2021.
- Gyon Technologies Capital Management opened 181 new positions and closed 160 in Q3 2021.
- Gyon Technologies Capital Management's portfolio value rose 22% quarter-over-quarter to $371M.
Based on Gyon Technologies Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.